Related Experiment Videos
Salmonella meningitis in infancy
Abstract:
Despite adequate treatment, mortality and morbidity were high among the 13 cases of Salmonella meningitis in this series. Chloramphenicol, being a bacteriostatic agent against Salmonella species, is not a suitable antibiotic for the treatment of Salmonella meningitis. Treatment for 4-6 weeks is recommended with use of an antibiotic capable of achieving an adequate bactericidal concentration in the cerebrospinal fluid such as moxalactam. Intraventricular antibiotic treatment should be considered if there is a delay in the eradication of the Salmonella organisms from the cerebrospinal fluid after starting treatment.
Insights
High mortality and morbidity were observed in Salmonella meningitis cases despite treatment. Chloramphenicol is not recommended; bactericidal antibiotics like moxalactam for 4-6 weeks, potentially with intraventricular administration, are advised for Salmonella meningitis.
Area of Science:
- Infectious Diseases
- Microbiology
- Neurology
Background:
- Salmonella meningitis presents a significant challenge with high mortality and morbidity.
- Previous treatment strategies may be suboptimal due to the nature of the causative agent.
Purpose of the Study:
- To evaluate treatment outcomes for Salmonella meningitis.
- To identify more effective antibiotic strategies for Salmonella meningitis.
Main Methods:
- Retrospective case series analysis of 13 patients with Salmonella meningitis.
- Review of antibiotic efficacy and treatment durations.
Main Results:
- High mortality and morbidity rates were observed in the studied cases.
- Chloramphenicol demonstrated bacteriostatic effects, deeming it unsuitable.
- Extended treatment (4-6 weeks) with bactericidal antibiotics is suggested.
Conclusions:
- Chloramphenicol is not recommended for Salmonella meningitis due to its bacteriostatic action.
- Bactericidal antibiotics achieving adequate cerebrospinal fluid concentrations, such as moxalactam, are preferred.
- Intraventricular therapy should be considered for persistent infections.